Our diversity of skills and the collective experience of the team at Glycotope are what make us strong
The contribution of each individual employee is valued to constantly develop and improve our approach. We believe in supportive cooperation at every level of our company, as well as with our partners, to achieve our common goals.
Henner serves as CEO since 2017 prior to holding executive functions at Glycotope since 2014. He has more than 20 years of experience in management functions including strategy, finance, operations and venture capital.
Antje is responsible for the Research & Development operations. She is a biochemist specialized in the development of recombinant antibody-based therapeutics.
Patrik heads the Research & Development department. He is an immunologist specialized in the development of therapeutics in the field of oncology.
Head of Program Management
Johanna is an experienced biologist with 15+ years experience in developing pre-clinical drug leads in the field of oncology.
Interim Lead of Platform Development
Stephanie leads the Platform Development group on an interim basis. She is an immunologist with experience in preclinical development of anti-tumor vaccines, cell line development and recombinant protein expression and characterization.
Head of Finance & Controlling
Jenny serves as Head of Finance and Controlling since 2017. She has more than 12 years of experience in finance and controlling functions.
Sebastian serves as Legal Counsel at Glycotope. He is a business lawyer specialized in the fields of contract and company law.
Human Ressources Manager
Stella joined Glycotope in 2012.
She holds a degree from Freie Universität Berlin
with specialization in HR